Atıf Formatları
Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Ermis Et Al. , "Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study," BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3, pp.472-475, 2001

Ermis, O. Et Al. 2001. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3 , 472-475.

Ermis, O., Alpsoy, E., Cetin, L., & Yilmaz, E., (2001). Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3, 472-475.

Ermis, O Et Al. "Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study," BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3, 472-475, 2001

Ermis, O Et Al. "Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study." BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3, pp.472-475, 2001

Ermis, O. Et Al. (2001) . "Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study." BRITISH JOURNAL OF DERMATOLOGY , vol.145, no.3, pp.472-475.

@article{article, author={O Ermis Et Al. }, title={Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study}, journal={BRITISH JOURNAL OF DERMATOLOGY}, year=2001, pages={472-475} }